Rapid Hepatitis C Test Could Improve Diagnosis, Treatment
A simpler version of a test for the hepatitis C virus (HCV) may open testing to people in areas where medical care is limited. (Source: WebMD Health)
Source: WebMD Health - July 8, 2021 Category: Consumer Health News Source Type: news

Hepatitis C Antivirals May Fight SARS-CoV-2 Hepatitis C Antivirals May Fight SARS-CoV-2
Sofosbuvir/ledipasvir and nitazoxanide both appeared to clear SARS-CoV-2 infections in a preliminary trial.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 28, 2021 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

New Program to Develop Antivirals for COVID-19 New Program to Develop Antivirals for COVID-19
The Antiviral Program for Pandemics will allow the NIH to focus on antivirals for COVID-19 and other pandemic risks, including hemorrhagic fever and influenza, the way HIV and hepatitis C can be managed.WebMD Health News (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - June 17, 2021 Category: Infectious Diseases Tags: Infectious Diseases News Source Type: news

Hepatitis C Related Cognitive Impairment Hepatitis C Related Cognitive Impairment
This study assessed the prevalence and predictors of HCV-related cognitive impairment. Can it be reversed by anti-viral therapy?Journal of Viral Hepatitis (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - June 15, 2021 Category: Transplant Surgery Tags: Gastroenterology Journal Article Source Type: news

Malaysia registers first hepatitis C treatment developed through South-South cooperation
(Drugs for Neglected Diseases Initiative) New treatment combination for hepatitis C virus (HCV) is an additional affordable option for millions still waiting for access to lifesaving treatments in middle-income countries. Combination is safe and effective, including for hard-to-treat cases and people with HCV and HIV. New drug ravidasvir is the first HCV drug to be developed through South-South collaboration and with support from non-profit organizations. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 14, 2021 Category: International Medicine & Public Health Source Type: news

U.S. Food and Drug Administration Approves New Formulation of Epclusa, Expanding Pediatric Indication to Treat Children Ages 3 and Older With Chronic Hepatitis C
FOSTER CITY, Calif.--(BUSINESS WIRE)--Jun. 10, 2021-- Gilead Sciences, Inc. (Nasdaq: GILD) announced today that the U.S. Food and Drug Administration (FDA) has approved an expansion of the pediatric indication of Epclusa (sofosbuvir/velpatasvir) for... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - June 10, 2021 Category: Drugs & Pharmacology Source Type: news

Liver Transplant Outcomes Improving for US Patients With HIV/HCV Liver Transplant Outcomes Improving for US Patients With HIV/HCV
Hepatitis C virus (HCV) infection no longer confers worse patient survival in the era of direct-acting antiviral therapy, but the population remains underserved.Medscape Medical News (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - May 28, 2021 Category: Transplant Surgery Tags: Gastroenterology News Source Type: news

Africa: President Sisi Keen On Helping Africa Eradicate Hepatitis
[Egypt Online] President Abdel Fattah El Sisi is keen on supporting Africa in eliminating hepatitis through an initiative to treat one million Africans for hepatitis C, Health Minister Hala Zayed said. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - May 28, 2021 Category: African Health Source Type: news

MAFLD As a Part of the Global Hepatitis C Elimination Effort MAFLD As a Part of the Global Hepatitis C Elimination Effort
Increasing evidence suggests that metabolic-associated fatty liver disease and chronic hepatitis C frequently coexist, especially in in HCV patients with SVR. What are the implications?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 24, 2021 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Wife of patient reacts to blood inquiry statement
Su’s husband Steve was diagnosed with hepatitis C 21 years after first receiving contaminated blood products. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - May 21, 2021 Category: Consumer Health News Source Type: news

When Medicare chips in on hepatitis C treatment for Medicaid patients, everyone wins
(University of Southern California) USC Schaeffer Center researchers found Medicare has significant financial incentives to partner with Medicaid to treat the majority of hepatitis C cases. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 20, 2021 Category: Infectious Diseases Source Type: news

Opt-Out Increases Hepatitis C Screening Uptake
WEDNESDAY, May 19, 2021 -- Twice as many eligible patients get screened for hepatitis C virus (HCV) if it is already ordered for them at the time of a reminder, according to a study published online May 18 in The BMJ. Shivan J. Mehta, M.D., from the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 19, 2021 Category: Pharmaceuticals Source Type: news

Drops in Hepatitis C Testing, Treatment Spark Concern Drops in Hepatitis C Testing, Treatment Spark Concern
Prior to the pandemic, the goal was to eradicate this curable disease. Recent data suggest significant efforts will now be needed to make up for lost ground.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - May 19, 2021 Category: Gastroenterology Tags: Gastroenterology News Source Type: news

Drops in Hepatitis C Testing, Treatment
Spark Concern (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - May 19, 2021 Category: General Medicine Source Type: news

Why Do Patients With Chronic Hepatitis C Drink Alcohol? Why Do Patients With Chronic Hepatitis C Drink Alcohol?
This study examines how sociodemographic factors, chronic pain, and depression relate to the motivations of individuals with chronic HCV to consume alcohol.Journal of Viral Hepatitis (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 18, 2021 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news